Donald E. Bobo Jr. - 11 May 2026 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
12 May 2026, 16:52:39 UTC
Prior SEC filing
08 May 2026
Next SEC filing
18 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Linda J. Park, Attorney-in-Fact

Key filing fact

Donald E. Bobo Jr. filed Form 4 for Edwards Lifesciences Corp (EW) on 12 May 2026.

Key facts

  • This page summarizes Donald E. Bobo Jr.'s Form 4 filing for Edwards Lifesciences Corp (EW).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 12 May 2026, 16:52.

Change

  • Previous filing in this sequence was filed on 08 May 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001196661 Primary reporting owner

BOBO DONALD E JR

Relationship
CVP,Strategy/Corp Development
Address
ONE EDWARDS WAY, IRVINE
Signature
Linda J. Park, Attorney-in-Fact
Signature date
11 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EW transaction

Common Stock

Options Exercise

Transaction value
Shares
+13,457
Change %
+50%
Price
$0.000000*
Shares after
40,235
Date
11 May 2026
Ownership
Direct
Footnotes
F1
EW transaction

Common Stock

Tax liability

Transaction value
Shares
-7,469
Change %
-19%
Price
$79.96*
Shares after
32,766
Date
11 May 2026
Ownership
Direct
EW holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
38,970
Date
11 May 2026
Ownership
401(k)
EW holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
121,756
Date
11 May 2026
Ownership
By Trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EW transaction Derivative

Performance Rights

Options Exercise

Transaction value
Shares
-13,457
Change %
-100%
Price
$0.000000*
Shares after
0
Date
11 May 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
13,457
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4.

Footnote F2

These Performance Rights expire on May 10, 2030.

SEC remarks

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .